Endovascular pulmonary arterial fiducial marker placement for particle radiotherapy using proton or carbon-ion beams for lung cancer
Journal of Radiation Research · 26.05.2026 · 67 (3) · 430-435
DOI: 10.1093/jrr/rrag022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Radiation Research, online erschienen am 23.04.2026. Verfasst von Kazuki Terashima und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Hyogo Ion Beam Medical Center, 1-2-1 Kouto, Shingu-cho, Tatsuno, Hyogo 679-5165, Japan. Hauptthemen laut MEDLINE: Fiducial Markers, Lung Neoplasms, Proton Therapy, Heavy Ion Radiotherapy. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study evaluated the safety, feasibility and efficacy of endovascular pulmonary arterial fiducial marker (EVFM) placement for image-guided particle therapy using proton or carbon-ion beams in patients with primary or metastatic lung cancer. Methods: A 5F catheter system was used to insert platinum coil markers via the right femoral vein into a distal pulmonary artery near the tumor under fluoroscopic guidance. Tumor-to-marker distances, marker migration and therapy completion were assessed. From July 2016 to January 2019, 54 patients (38 men, 16 women; median age, 71 years) with 46 primary and 8 metastatic lung tumors underwent marker placement. Tumors were located in 33 right and 21 left lobes, with a median diameter of 22 mm. Ten patients received proton therapy, and 44 received carbon-ion therapy. There were no marker placement related complications. Transient arrhythmias occurred only when the guide wire passed through the right ventricle. Tumor-to-marker distances ranged from 0–17 mm (median, 5 mm). Migration during irradiation was minimal (median, 0 mm); one case showed a 4-mm shift due to lung deformation, not marker displacement. All patients completed scheduled therapy without marker migration. EVFM placement is a feasible and safe alternative to computed tomography- or bronchoscopy-guided fiducial marker placement, offering accurate localization with minimal complications or marker migration in particle therapy for lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Hyogo Ion Beam Medical Center, 1-2-1 Kouto, Shingu-cho, Tatsuno, Hyogo 679-5165, Japan.
- Department of Radiology, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuouku, Kobe, Hyogo 650-0017, Japan.
- Department of Radiation Oncology, Hyogo Ion Beam Medical Center Kobe Proton Center, 1-6-8, Minamicho, Minatozima, Chuouku, Kobe, Hyogo 650-0047, Japan.
ORCID-Profile: Kazuki Terashima, Yusuke Demizu, Sunao Tokumaru
Zitieren
APA
Terashima, K., Gentsu, T., Takahashi, D., Matsuo, Y., Niwa, Y., Demizu, Y., Tokumaru, S., & Okimoto, T. (2026). Endovascular pulmonary arterial fiducial marker placement for particle radiotherapy using proton or carbon-ion beams for lung cancer. Journal of Radiation Research, 67(3), 430-435. https://doi.org/10.1093/jrr/rrag022
Vancouver
Terashima K, Gentsu T, Takahashi D, Matsuo Y, Niwa Y, Demizu Y, et al. Endovascular pulmonary arterial fiducial marker placement for particle radiotherapy using proton or carbon-ion beams for lung cancer. Journal of Radiation Research. 2026;67(3):430-435. doi:10.1093/jrr/rrag022
BibTeX
@article{Terashima2026,
author = {Terashima, Kazuki and Gentsu, Tomoyuki and Takahashi, Daiki and Matsuo, Yoshiro and Niwa, Yasue and Demizu, Yusuke and Tokumaru, Sunao and Okimoto, Tomoaki},
title = {Endovascular pulmonary arterial fiducial marker placement for particle radiotherapy using proton or carbon-ion beams for lung cancer},
journal = {Journal of Radiation Research},
year = {2026},
volume = {67},
number = {3},
pages = {430--435},
doi = {10.1093/jrr/rrag022}
}
EUVIMED